The global compression therapy market size is projected to reach USD 4.51 billion by 2026, exhibiting a CAGR of 5.2% during the forecast period. Rising prevalence of cancer will be a key growth driver for this market in the coming decade, finds Fortune Business Insights™ in its report, titled “Compression Therapy Market Size, Share and Industry Analysis By Product (Compression Garments {Compression Bandages, Compression Stockings, and Others}, Compression Pumps, and Others), By Application (Venous Leg Ulcer, Deep Vein Thrombosis (DVT), Lymphedema, and Others), By End User (Hospitals & Clinics, Nursing Care Centers, Home Care, and Others), and Regional Forecast, 2019-2026”. The global disease burden of cancer, according to the International Agency for Research on Cancer (IARC), rose by an estimated 18.1 million new cases in 2018.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/compression-therapy-market-...

Increasing Geriatric Population to Stoke Growth

The world population is aging at an astonishing rate. Demographic analysis of the UN Department of Economic and Social Affairs (DESA) suggests that by 2050, the number of people aged 60 years and above is set to double, reaching 2.1 billion. Aging entails a host of health problems and vein disorders are some of the most common ailments that inflict older people. For example, old age is a high risk factor for varicose veins as the wear & tear of valves in the veins causes the blood to flow back into the veins instead flowing towards the heart. Similarly, the incidence of deep vein thrombosis is high among the geriatric population due to reduced physical movement. Thus, expanding aging population worldwide is expected to be a major demand-puller for compression therapies, thereby augmenting the compression treatment market growth.

Healthy R&D Funding to Fuel the Market in North America

The market size in North America stood at USD 1.05 billion in 2018 backed by concerted investment in healthcare research and development by the private and public sectors. In addition to that, rising geriatric population and strong presence of global companies is anticipated to aid the region to dominate the compression therapy market share during the forecast period. In Europe, the primary growth propeller will be the development and launch of innovative products by players in the region. On the other hand, steadily increasing number of patients with lymphatic and venous conditions is expected to augur well for the market in Asia-Pacific.